BACKGROUND: Cardiac development is a complex and multifactorial biological process. Heterozygous mutations in the transcription factor NKX2.5 are between the first evidence of a genetic cause for congenital heart defects in human beings. In this study, we evaluated the presence and frequency of mutations in the NKX2.5 gene on 159 unrelated patients with a diverse range of non-syndromic congenital heart defects (conotruncal anomalies, septal defects, left-sided lesions, right-sided lesions, patent ductus arteriosus and Ebstein's anomaly). METHODS: The coding region of the NKX2.5 locus was amplified by polymerase chain reaction and mutational analysis was performed using denaturing high performance liquid chromatography (DHPLC) and DNA sequencing. RESULTS: We identified two distinct mutations in the NKX2.5 coding region among the 159 (1.26%) individuals evaluated. An Arg25Cys mutation was identified in a patient with Tetralogy of Fallot. The second mutation found was an Ala42Pro in a patient with Ebstein's anomaly. CONCLUSIONS: The association of NKX2.5 mutations is present in a small percentage of patients with non-syndromic congenital heart defects and may explain only a few cases of the disease. Screening strategies considering the identification of germ-line molecular defects in congenital heart disease are still unwarranted and should consider other genes besides NKX2.5. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.
BACKGROUND: Cardiac development is a complex and multifactorial biological process. Heterozygous mutations in the transcription factor NKX2.5 are between the first evidence of a genetic cause for congenital heart defects in human beings. In this study, we evaluated the presence and frequency of mutations in the NKX2.5 gene on 159 unrelated patients with a diverse range of non-syndromic congenital heart defects (conotruncal anomalies, septal defects, left-sided lesions, right-sided lesions, patent ductus arteriosus and Ebstein's anomaly). METHODS: The coding region of the NKX2.5 locus was amplified by polymerase chain reaction and mutational analysis was performed using denaturing high performance liquid chromatography (DHPLC) and DNA sequencing. RESULTS: We identified two distinct mutations in the NKX2.5 coding region among the 159 (1.26%) individuals evaluated. An Arg25Cys mutation was identified in a patient with Tetralogy of Fallot. The second mutation found was an Ala42Pro in a patient with Ebstein's anomaly. CONCLUSIONS: The association of NKX2.5 mutations is present in a small percentage of patients with non-syndromic congenital heart defects and may explain only a few cases of the disease. Screening strategies considering the identification of germ-line molecular defects in congenital heart disease are still unwarranted and should consider other genes besides NKX2.5. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.
Authors: Justin P Zachariah; Edward P Walsh; John K Triedman; Charles I Berul; Frank Cecchin; Mark E Alexander; Laura M Bevilacqua Journal: Am Heart J Date: 2012-11-20 Impact factor: 4.749
Authors: Miguel A Alcántara-Ortigoza; Jesús De Rubens-Figueroa; Miriam E Reyna-Fabian; Bernardette Estandía-Ortega; Ariadna González-del Angel; Bertha Molina-Álvarez; José A Velázquez-Aragón; Sandra Villagómez-Martínez; Gabriela I Pereira-López; Víctor Martínez-Cruz; Víctor Cruz-Martínez; Rosa M Álvarez-Gómez; Luisa Díaz-García; Luisa García-Díaz Journal: Pediatr Cardiol Date: 2014-12-19 Impact factor: 1.655
Authors: Ossama K Abou Hassan; Akl C Fahed; Manal Batrawi; Mariam Arabi; Marwan M Refaat; Steven R DePalma; J G Seidman; Christine E Seidman; Fadi F Bitar; Georges M Nemer Journal: Sci Rep Date: 2015-03-06 Impact factor: 4.379